Altavant Sciences
is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases... Read moreAltavant Sciences
is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases... Read more
2018
PrivateMerger Pending with Enzyvant Therapeutics, Inc
News
Dec 08, 2022
PMLiVE
Altavant Sciences: Enzyvant and Altavant announce merger to accelerate rare disease therapies
May 06, 2022
FirstWord Pharma
Altavant Sciences: Altavant Sciences Presents Data Showing Potential For Combination Of Rodatristat Ethyl And Ambrisentan In Model Of Pulmonary Arterial Hypertension
May 02, 2022
Markets Insider
Altavant Sciences: ALTAVANT SCIENCES PRESENTED DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530
Apr 25, 2022
Markets Insider
Altavant Sciences: ALTAVANT SCIENCES TO PRESENT DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530
Sep 13, 2021
Markets Insider
Altavant Sciences: Altavant Sciences Highlights Ongoing Phase 2b ELEVATE 2 Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension at European Respiratory Society Annual Congress
May 10, 2021
Markets Insider
Altavant Sciences: Altavant Sciences Provides Update on Clinical Plan for PAH Candidate, Rodatristat Ethyl, at Upcoming American Thoracic Society Annual Meeting
May 06, 2021
GlobalNewswire
Press Release: Altavant Sciences : Altavant Sciences Advances Rodatristat Ethyl into Phase 2b Clinical Trial for Pulmonary Arterial Hypertension
Apr 26, 2021
MarketScreener
Altavant Sciences: Cary, N.C. and Basel, Switzerland s Finds Nebulized ALTA-2530 Retains Potency and Reaches Target Lung Tissues, Supporting Continued Investigation for Treatment of BOS
Apr 21, 2021
GlobalNewswire
Press Release: Altavant Sciences : Altavant Sciences Highlights Pipeline Progress in PAH and BOS at the International Society for Heart & Lung Transplantation Meeting
Feb 18, 2021
MarketScreener
Altavant Sciences: Altavant Sciences Initiates Chemical Lung Injury Program in Collaboration with the BARDA and NIAID
Altavant Sciences Competitors
1
2
3
4
5
6
7
8
9
10